| Aggregate Evidence Quality . | Grade B . |
|---|---|
| Benefits | Detection of proteinuria among children with CKD and HTN may foster early detection and treatment of children at risk for more advanced renal disease |
| Risks, harm, cost | Additional testing |
| Benefit–harm assessment | Benefit of detection of a higher-risk group exceeds the risk of testing |
| Intentional vagueness | Whether to screen children with HTN without CKD for proteinuria |
| Role of patient preferences | None |
| Exclusions | Children without CKD |
| Strength | Strong recommendation |
| Key references | 47,484 |
| Aggregate Evidence Quality . | Grade B . |
|---|---|
| Benefits | Detection of proteinuria among children with CKD and HTN may foster early detection and treatment of children at risk for more advanced renal disease |
| Risks, harm, cost | Additional testing |
| Benefit–harm assessment | Benefit of detection of a higher-risk group exceeds the risk of testing |
| Intentional vagueness | Whether to screen children with HTN without CKD for proteinuria |
| Role of patient preferences | None |
| Exclusions | Children without CKD |
| Strength | Strong recommendation |
| Key references | 47,484 |